InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

EXELIXIS, INC.

EXEL Clue Score84
United States Fiscal year ends January CIK 0000939767 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
Maria C Freire
7 May 2026
Director
Sold after exercise
20,634
$46.00
$949.16K
Mary C Beckerle
7 May 2026
Director
Sold after exercise
7,712
$48.45
$373.65K
Julie Smith
18 Feb 2026
Director
Sold after exercise
20,030
$44.30
$887.33K
Julie Smith
18 Feb 2026
Director
Sold after exercise
44,087
$44.50
$1.96M
Jack L Wyszomierski
18 Feb 2026
Director
Sold after exercise
99,574
$44.01
$4.38M
Julie Smith
17 Feb 2026
Director
Sold after exercise
42,422
$43.33
$1.84M
Bob Oliver
13 Feb 2026
Director
Sold after exercise
21,162
$43.90
$929.01K
Bob Oliver
13 Feb 2026
Director
Sold after exercise
9,088
$43.61
$396.33K
Mary C Beckerle
11 Nov 2025
Director
Sold after exercise
18,838
$41.90
$789.31K
Mary C Beckerle
11 Nov 2025
Director
Sold after exercise
5,784
$42.03
$243.10K
Show all 34 transactions →

What was left out

Form 4 filings counted 53
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 10
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 4,810,436
History held since 6 Oct 2006